The global In Vitro Diagnostics Market, valued at US$100,769.3 million in 2024, is forecasted to grow at a robust CAGR of 7.6%, reaching US$109 ...

ADMA Biologics ADMA reported lower-than-expected results for the first quarter. Adjusted earnings per share of 14 cents missed the Zacks Consensus Estimate of 16 cents. Revenues of $114.8 million (up ...

Every day, doctors across various specialties diagnose cases of inflammatory arthritis, enteropathy, hyperinsulinemic ...